FluiDx-AD

FluiDx-AD seeks to develop a trio of complementary tests: SalivaDx-AD: An easy-to-use, at-home saliva test for population-wide detection of individuals at risk of developing AD in its prodromal stages. PlasmaDx-AD: A minimally invasive and cost-effective blood test for high-precision confirmatory diagnosis for individuals with suspected AD. BloodCellDx-AD: A minimally invasive, whole blood ex vivo test system to evaluate the risk of amyloid-related imaging abnormalities (ARIA), to support patient eligibility assessments and ARIA monitoring for anti-amyloid therapies